MedTrace Logo

Myeloid-derived Suppressor Cells in Colorectal Cancer

NCT04943419 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-07-07

No results posted yet for this study

Summary

The aim of the study is to evaluate whether the preoperative level of myeloid-derived suppressor cells is associated with postoperative complications classified by Clavien-Dindo categories. Levels of all MDSC, polymorphonuclear MDSC (PMNMDSC), monocytic MDSC (MMDSC), early-stage MDSC (EMDSC) and monocytic to polymorphonuclear MDSC ratio (M/PMN MDCS) were established and compared in patients with postoperative complications, severe postoperative complications (\>= IIIA according to Clavien-Dindo) and severe septic complications.

Conditions

Interventions

DIAGNOSTIC_TEST

Level of Myeloid-Derived Suppressor Cells

Establishing of levels of all MDSC, PMNMDSC, MMDSC, EMDSC, M/PMN MDSC ratio on the day before operation.

Sponsors & Collaborators

  • Jagiellonian University

    lead OTHER

Principal Investigators

  • Radoslaw Pach, Ph.D. · Jagiellonian University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2021-02-27
Completion
2021-06-21

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04943419 on ClinicalTrials.gov